|
Common Template for initial assessment of Nitrosamine impurities
|
|
0
|
666
|
June 20, 2024
|
|
Insights from the Lhasa Limited and IPEC Europe Nitrites collaborative meeting
|
|
1
|
522
|
June 16, 2024
|
|
🇺🇸 FDA - Fiscal Year 2024 Generic Drug Science and Research Initatives Public Workshop
|
|
20
|
1936
|
September 5, 2024
|
|
🇲🇽 Conferencia USP Nitrosaminas en México presencial 21-Marzo
|
|
4
|
768
|
May 27, 2024
|
|
Managing the complexities of NDSRI method development: The N-nitroso propranolol case story
|
|
0
|
538
|
May 14, 2024
|
|
Using the Carcinogenicity Potency Categorization Algorithm to Predict N-Nitrosamine Carcinogenicity -Webinar
|
|
0
|
363
|
May 13, 2024
|
|
🇺🇸 FDA CDER Generic Drug Forum (GDF) 2024
|
|
5
|
1389
|
April 14, 2024
|
|
📅 Ascorbic Acid And Alpha-Tocopherol As Nitrite Scavengers - An Elegant And Simple Solution To Mitigate Nitrosamines In Drug Products -Event
|
|
0
|
883
|
April 5, 2024
|
|
USP User Forum in 🇨🇦 Toronto
|
|
0
|
241
|
March 12, 2024
|
|
Read-across Masterclass: How To Facilitate Your Acceptable Intake Limit Setting For Nitrosamines
|
|
0
|
378
|
March 7, 2024
|
|
HESI Open call to Q(SAR) and QM working group
|
|
3
|
767
|
February 20, 2024
|
|
TALK SERIES: Navigating Nitrosamine and NDSRIs regulations with Dr. Reddy´s Laboratories
|
|
1
|
769
|
February 11, 2024
|
|
Exploring the CPCA Framework: Defining Acceptable Intake for NDSRIs -Event
|
|
2
|
897
|
January 10, 2024
|
|
Upcoming and recorded Lhasa webinars
|
|
3
|
906
|
December 21, 2023
|
|
Nitrosamine Impurities Deadline: Are Your Products Compliant?
|
|
6
|
702
|
December 6, 2023
|
|
8th Impurities: Genotoxic, Nitrosamine, & Beyond Summit
|
|
1
|
1065
|
December 1, 2023
|
|
10º encontro Farmacopeia Brasileira
|
|
0
|
516
|
November 30, 2023
|
|
Free Webinar: Nitrosamines in Drug Products
|
|
12
|
1865
|
November 16, 2023
|
|
Nitrosamine Risk Reduction In Pharmaceutical Formulations Webinar
|
|
1
|
883
|
November 6, 2023
|
|
USP, EDQM, JP, IPC through Pharmacopeial Discussion Group on Nitrosamines
|
|
2
|
503
|
November 2, 2023
|
|
FDA - Pharmaceutical Quality Symposium
|
|
1
|
825
|
November 1, 2023
|
|
Useful interactive vedios on Nitrosamines Impuririties
|
|
2
|
412
|
November 1, 2023
|
|
Post any educational in-person event here!
|
|
2
|
785
|
November 9, 2023
|
|
Personal perspective on N-Nitrosamines and recent revision of guidelines
|
|
7
|
799
|
October 27, 2023
|
|
PAQ Experts Forum on Handling Nitrosamines & NDSRIs in Pharmaceuticals - to be held in Ahmedabad, Gujarat on 27th October, 2023
|
|
1
|
440
|
October 23, 2023
|
|
The Recent Discoveries of Nitrosamine Impurities (PDA/FDA Joint Regulatory Conference 2023)
|
|
1
|
659
|
October 22, 2023
|
|
AAM GRx + Biosims 2023 -Event
|
|
5
|
516
|
October 16, 2023
|
|
Managing Nitrite Impurities: A Combined Supplier-Manufacturer View to Nitrosamine Risks
|
|
3
|
1015
|
October 3, 2023
|
|
Uso de herramientas in-silico para Nitrosaminas
|
|
0
|
419
|
October 2, 2023
|
|
Optimized method development strategies for the quantification of small and complex N-nitrosamines impurities
|
|
0
|
477
|
August 25, 2023
|